№ 152 · biology

An antibody is a shape, not a potion

An antibody is not a chemical that dissolves a germ. It is a glycoprotein whose two arms end in a variable region, and the amino acid sequence there fixes a three-dimensional shape. Parker and colleagues describe the basic monomer as four chains joined by disulfide bonds into a Y. The surprise is that the binding end is a surface, not a substance.

What the Y is made of

Parker and colleagues lay out the parts. Two identical heavy chains and two identical light chains form the Y. The arms are the Fab region, short for fragment of antigen binding, and the far end of each arm is the variable region. That region's sequence sets the three-dimensional shape, and therefore which epitope it can hold. The trunk and the lower arm portions form the constant region, and the trunk is the Fc region, which binds complement factors and phagocytic cells. The constant region also sets the antibody's class: IgG, IgM, IgA, IgD or IgE.

Predict first

Two antibodies are raised against the same protein antigen. Must they grip the same spot?

Check your answer

No. Parker and colleagues state that one antigen may carry several epitopes, and different antibodies may bind different ones.

Binding is shape meeting shape

Parker and colleagues define an epitope as a small exposed patch on an antigen's surface. Antibodies and T cells read those patches, not the whole molecule. A bacterial flagellum can carry hundreds or thousands of distinct epitopes. Liu and colleagues add that the antibody side of the contact is called the paratope, and that in conventional IgG the paratope is usually a cavity, a groove or a flat surface. Liu and colleagues report that single-domain antibodies, which keep only the heavy-chain variable region, instead present a convex “rugby ball” paratope that can reach into recessed clefts.

Where cross-reactivity comes in

Parker and colleagues describe specificity as arising from the antigen-binding site inside the variable regions, whose amino acid pattern fits a target with complementary charges and noncovalent bonds. Liu and colleagues cite an X-ray study in which single-domain and conventional antibodies against the same antigens formed similar non-covalent interactions. Specificity has limits: an antibody raised against one antigen can also bind a chemically similar one. Parker and colleagues call that cross-reactivity, and note it is likelier when affinity, the strength between one binding site and one epitope, or avidity, the summed strength of the whole complex, is low.

One shape or a mixture

Parker and colleagues explain that a complex antigen with many epitopes drives many B-cell clones, giving a polyclonal response. Monoclonal antibodies instead come from hybridomas, fused B cells and myeloma cells, screened so that every molecule recognises a single epitope. As of 2016, Parker and colleagues report that humanised monoclonals such as Herceptin have treated some breast cancers, while trials for infectious disease had not produced treatments in use. They also note monoclonals can be too specific, missing some strains, and that cost has blocked practical use against microbial infections.

Interactive Move the paratope slider to change the antibody's binding surface, then press new antigen to redraw the epitope patches.

Schematic only. The antigen is a bar with three epitope patches, each with a shape value from 0 to 100; the antibody's paratope has its own value, set by the slider. A patch is marked as bound when the two values are within 10 units; the values, the 10-unit tolerance and the count of bound patches are illustrative, not measured, and the count is not a measure of affinity or avidity. The patch values are dealt from a fixed-seed generator, so the same clicks give the same antigen.

In short

An antibody works by holding a shape that matches an epitope. The variable region supplies that shape, the constant region supplies the class and the downstream jobs, and a single antigen can offer several epitopes to different antibodies.

Where this comes from

  1. Microbiology, 18.1 Overview of Specific Adaptive Immunity (OpenStax) linked only, not reproduced
    Parker, Schneegurt, Thi Tu, Lister, Forster · 2016
    openstax.org/books/microbiology/pages/18-1-overview-of-specific-adaptive-immunity
  2. Microbiology, 20.1 Polyclonal and Monoclonal Antibody Production (OpenStax) linked only, not reproduced
    Parker, Schneegurt, Thi Tu, Lister, Forster · 2016
    openstax.org/books/microbiology/pages/20-1-polyclonal-and-monoclonal-antibody-production
  3. Research progress on unique paratope structure, antigen binding modes, and systematic mutagenesis strategies of single-domain antibodies (Front. Immunol. 13:1059771) linked only, not reproduced
    Liu, Lin, Cao, Wang, Sui · 2022
    www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1059771/full